Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by FredTheVoiceon Apr 17, 2018 9:19am
177 Views
Post# 27896239

Opinion ?

Opinion ?
PoorOpinion wrote: "Fred is clearly floating above us, good luck with that".

Well. I know that I am Optimistic. Yes I see this stock around 15 $ this summer. I presume positively that the penetration of TROGARZO will be GOOD, not great, but good. Great means, 20$ a share in my opinion.

I'm sur that you have in mind a stock that doubled lately on good news after a positive second phase test on a molecule.......here we are taking of a life saving drug that WAS approved, with the first sales being made this week !

Come on PoorOpinion, tell us a little about your opinion about this stock (stock price) forr the near future ..... 9,85$ if the lauch of Trogarzo is great ? 9,99$ if its awesome ?

Some on this board see this stock over 40$ in two years............I guess i'm just realistic.

FTV.

Bullboard Posts